Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group
PROTEOMICS – Clinical Applications · 2023
DOI: 10.1002/prca.202200109 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2023. Verfasst von Fieke W Hoff und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Endoplasmic Reticulum Chaperone BiP. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, St. Baldrick's Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
The endoplasmic reticulum (ER) is the major site of protein synthesis and folding in the cell. ER‐associated degradation (ERAD) and unfolded protein response (UPR) are the main mechanisms of ER‐mediated cell stress adaptation. Targeting the cell stress response is a promising therapeutic approach in acute myeloid leukemia (AML). Experimental Design Protein expression levels of valosin‐containing protein (VCP), a chief element of ERAD, were measured in peripheral blood samples from in 483 pediatric AML patients using reverse phase protein array methodology. Patients participated in the Children's Oncology Group AAML1031 phase 3 clinical trial that randomized patients to standard chemotherapy (cytarabine (Ara‐C), daunorubicin, and etoposide [ADE]) versus ADE plus bortezomib (ADE+BTZ).
Results
Low‐VCP expression was significantly associated with favorable 5‐year overall survival (OS) rate compared to middle‐high‐VCP expression (81% versus 63%, p < 0.001), independent of additional bortezomib treatment. Multivariable Cox regression analysis identified VCP as independent predictor of clinical outcome. UPR proteins IRE1 and GRP78 had significant negative correlation with VCP. Five‐year OS in patients characterized by low‐VCP, moderately high‐IRE1 and high‐GRP78 improved after treatment with ADE+BTZ versus ADE (66% versus 88%, p = 0.026). Conclusion and Clinical Relevance Our findings suggest the potential of the protein VCP as biomarker in prognostication prediction in pediatric AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- COG Statistics and Data Center, Monrovia, California, USA.
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
- Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
ORCID-Profile: Fieke W Hoff
Förderung
- NCI NIH HHS
- St. Baldrick's Foundation
Zitieren
APA
Hoff, F. W., Qiu, Y., Brown, B. D., Gerbing, R. B., Leonti, A. R., Ries, R. E., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T. A., Meshinchi, S., Jenkins, G. N., Horton, T. M., & Kornblau, S. M. (2023). Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202200109
Vancouver
Hoff FW, Qiu Y, Brown BD, Gerbing RB, Leonti AR, Ries RE, et al. Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group. PROTEOMICS – Clinical Applications. 2023. doi:10.1002/prca.202200109
BibTeX
@article{Hoff2023,
author = {Hoff, Fieke W and Qiu, Yihua and Brown, Brandon D and Gerbing, Robert B and Leonti, Amanda R and Ries, Rhonda E and Gamis, Alan S and Aplenc, Richard and Kolb, Edward Anders and Alonzo, Todd A and Meshinchi, Soheil and Jenkins, Gaye N and Horton, Terzah M and Kornblau, Steven M},
title = {Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group},
journal = {PROTEOMICS – Clinical Applications},
year = {2023},
doi = {10.1002/prca.202200109}
}
EUVIMED